Lasa Supergenerics - Quaterly Results

14 Feb 2026 Evaluate
The Sales for the quarter ended December 2025 of Rs. 21.99 million declined by -93.35% from Rs. 330.80 millions.The Net Loss for the quarter ended December 2025 is Rs. -25.56 millions as compared to Net Profit of Rs. 54.94 millions of corresponding quarter ended December 2024Operating profit Margin for the quarter ended December 2025 slipped to -7.31% as compared to 9.33% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 21.99 330.80 -93.35 252.72 1033.11 -75.54 1424.48 1043.35 36.53
Other Income 0.18 6.69 -97.31 1.59 26.21 -93.93 50.12 1.02 4813.73
PBIDT -7.31 9.33 -178.35 -50.91 54.74 -193.00 112.77 22.64 398.10
Interest 1.12 4.72 -76.27 2.58 25.85 -90.02 26.92 19.32 39.34
PBDT -8.43 87.06 -109.68 -259.24 111.34 -332.84 -70.84 -84.41 -16.08
Depreciation 15.70 27.96 -43.85 47.10 84.01 -43.94 123.00 106.73 15.24
PBT -24.13 59.10 -140.83 -306.34 27.33 -1220.89 -193.84 -191.14 1.41
TAX 1.43 4.16 -65.63 -7.05 31.99 -122.04 -46.26 26.18 -276.70
Deferred Tax 1.43 4.16 -65.63 -7.05 31.99 -122.04 -46.26 26.18 -276.70
PAT -25.56 54.94 -146.52 -299.29 -4.66 6322.53 -147.58 -217.32 -32.09
Equity 501.01 501.01 0.00 501.01 501.01 0.00 501.01 501.01 0.00
PBIDTM(%) -33.24 2.82 -1278.64 -20.14 5.30 -480.19 7.92 2.17 264.84

Lasa Supergenerics Share Price

7.10 -0.49 (-6.46%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×